Tag Archives: from

Must-Reads Of The Week From Brianna Labuskes

The Friday Breeze Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend. Happy Friday, where we’re 20 days and so-and-so hours (depending on when you read this) into the partial federal shutdown. As of today, it’s tied as the… Read More »

Supreme Court rebuffs appeals from Merck, Gilead in 2 high-profile drug battles

Monday was a good-news-bad-news day for Gilead Sciences at the U.S. Supreme Court, with the justices handing down multiple decisions about which appeals they would take up as they headed back to work after the holiday break. SCOTUS refused to hear Gilead’s appeal in a whistleblower case alleging it lied to the FDA about unapproved… Read More »

Stopping cancer from recruiting immune system double agents

Cancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the body; the tumors actually put myeloid cells to work helping them grow and metastasize (spread). A research team co-led by scientists at Rush University Medical Center have discovered a potential therapy that can disrupt… Read More »